Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05434013 · ClinicalTrials.gov registry record · NA
The Impact of Cigarillo Warnings on Purchasing
A NA study of Cigar Smoking, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 1,578
- Enrollment target
- 1
- Study location
NCT05434013: Completed NA study of Cigar Smoking, sponsored by Boston University.
NCT05434013 is a NA study of Cigar Smoking that has completed, run by Boston University. The registered enrollment target is 1,578 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05434013, a NA study of Cigar Smoking, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,578 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos. A previous study has identified that pictorial cigarillo warnings are perceived as more effective, but more information is needed on their impact. This study will address this issue by randomizing participants to see different cigarillo warning formats on cigarillo products within an online experimental tobacco marketplace. Participants will be cigarillo users who are ages 21-35.
Primary Outcome
Participants in each arm will participate in six mock shopping trips with a specified budget. They will purchase (mock) single cigarillos. The primary outcome is the average number of cigarillos purchased during each of the six mock shopping trips.
Conditions Studied
Interventions
- BEHAVIORAL Cigarillo warnings-Surgeon General Text-Only
- BEHAVIORAL Cigarillo warnings-FDA proposed text-only
- BEHAVIORAL Cigarillo warnings-Pictorial
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,578 participants |
| Start Date | 2022-06-24 |
| Est. Completion | 2022-07-21 |
| Phase | NA |
What the finished NCT05434013 record still lists
NCT05434013 is an interventional study that assigns participants to a tested intervention. Its 1,578 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Cigar Smoking appearing as the primary indexed condition, and to 3 interventions - of which Cigarillo warnings-Surgeon General Text-Only is the first listed.
NCT05434013 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05434013 about?
NCT05434013 is a clinical study titled "The Impact of Cigarillo Warnings on Purchasing". The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos. A previous study has identified that pictorial cigarillo warnings are perceived as more effective, but more info...
What is the current status of trial NCT05434013?
This trial is currently completed. It is a NA study. The enrollment target is 1,578 participants. The study started on 2022-06-24. Estimated completion is 2022-07-21.
What conditions does trial NCT05434013 study?
This clinical trial studies the following conditions: Cigar Smoking.
What interventions are being tested in trial NCT05434013?
The interventions under investigation include: Cigarillo warnings-Surgeon General Text-Only (BEHAVIORAL), Cigarillo warnings-FDA proposed text-only (BEHAVIORAL), Cigarillo warnings-Pictorial (BEHAVIORAL).
Who is sponsoring clinical trial NCT05434013?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05434013 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigar Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05434013's enrollment target sits among peer trials
1,578 64th of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT05552222 · 1,590 participants · Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- NCT06632457 · 1,590 participants · Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI